Zhang Yong, Wu Jie, Huang Wei, Wang Ying, Rivera Galvis Lidys, Chen Tiane, Han Bing
Department of Pathology and Laboratory Medicine, Penn State Health Milton S. Hershey Medical Center, Penn State College of Medicine Hershey, PA 17033, USA.
Department of Pathology, Shanghai Jiahui International Hospital Xuhui District, Shanghai 200233, China.
Int J Clin Exp Pathol. 2023 Feb 15;16(2):40-47. eCollection 2023.
Breast conservation therapy (BCT) or lumpectomy followed by radiation has been established as a preferred treatment for most patients with early-stage invasive breast cancer. About 20-40% of patients after initial lumpectomy will have to undergo re-excision due to a positive margin.
To determine the factors predicting higher risk of positive resection margin, we retrospectively analyzed 409 patients who underwent initial lumpectomy for invasive breast cancer from January 2019 through November 2022. Based on microscopic examination, the samples were divided into 3 subgroups with positive, close, or clean margins.
Positive margin was more frequently associated with larger tumor size (P<0.0001), specified histologic type (P<0.0001), higher tumor grade (P=0.004), multifocality (P<0.0001), positive lymph node status (P=0.0005), and lymphovascular invasion (P=0.0007). Other factors were not significantly associated with margin status including HER2/ER/PR status, presence of carcinoma in situ component, age at diagnosis, and history of neoadjuvant chemotherapy.
From the clinical practice of individual institution, identification and comprehensive assessment of these pathologic predictors will be useful for clinical management and intraoperative surgical-decision-making to reduce the rate of re-excision.
保乳治疗(BCT)或乳房肿瘤切除术加放疗已被确立为大多数早期浸润性乳腺癌患者的首选治疗方法。初次乳房肿瘤切除术后约20%-40%的患者因切缘阳性而需接受再次切除。
为确定预测切除缘阳性风险较高的因素,我们回顾性分析了2019年1月至2022年11月期间因浸润性乳腺癌接受初次乳房肿瘤切除术的409例患者。根据显微镜检查,样本被分为切缘阳性、切缘接近或切缘阴性3个亚组。
切缘阳性更常与肿瘤较大(P<0.0001)、特定组织学类型(P<0.0001)、肿瘤分级较高(P=0.004)、多灶性(P<0.0001)、淋巴结阳性状态(P=0.0005)和淋巴管浸润(P=0.0007)相关。其他因素与切缘状态无显著关联,包括HER2/ER/PR状态、原位癌成分的存在、诊断时的年龄以及新辅助化疗史。
从单个机构的临床实践来看,识别和综合评估这些病理预测因素将有助于临床管理和术中手术决策,以降低再次切除率。